Late Phase Clinical Development Solutions
An end-to-end suite of services for Phase II – III studies, focused on a rapid and professionally supported progress towards your drug’s approval, on-time, on budget.
Late Phase Clinical Development Solutions (P II – P III Studies)
By eliminating roadblocks on the path of your Phase II dose-finding and Phase III drug registration studies, we clear the way to proceed in a time and cost-efficient manner.
Our dedicated team of late phase clinical trial experts will support you to efficiently handle complexities and simplify your trial protocol, accelerate site selection, find and recruit quickly the right patient population, to reach compliance with both, international and local regulatory requirements and deliver high-quality study results on-time, on-budget.
WE OFFER END-TO-END SUITE OF SERVICES for Phase II – III studies, focused on a rapid and professionally supported progress towards your drug’s approval:
- Study design including Clinical development planning and Protocol development with medical and scientific consultation
- Global regulatory affairs, strategies, facilitation, operation
- Feasibility and Quick patient access through ACCELEROUTE™
- Recruitment and Enrollment
- Clinical Operations
- Safety and Risk Management
- Quality Assurance
- Data Management
- Advanced Biostatistics
- Clinical Programming
- Medical Writing
Feel free to ask Accelsiors’ Late Phase Clinical Development experts!
Let’s start discussing about how we can support your pipeline! Please, contact us:
Write Us
Call Us: +36 1 299 0091
Request for Proposal
and we will schedule a meeting around your calendar!
Learn more about our comprehensive clinical development services
Accelsiors offers a complete range of expertise in support of your specific needs: Scientific, analytical and regulatory complemented by global resources, state-of-the-art technologies and project management methodology for the most effective execution of your development program across all phases of clinical drug development.
